Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX – REVOLUTIOn trial
-
Published:2023-04
Issue:
Volume:20
Page:100466
-
ISSN:2667-193X
-
Container-title:The Lancet Regional Health - Americas
-
language:en
-
Short-container-title:The Lancet Regional Health - Americas
Author:
Maia Israel S.ORCID, Marcadenti Aline, Veiga Viviane C.ORCID, Miranda Tamiris A., Gomes Samara P.C., Carollo Mariana B.S., Negrelli Karina L., Gomes Jackeline O., Tramujas Lucas, Abreu-Silva Erlon O., Westphal Glauco A., Fernandes Ruthy P., Horta Jacques G.A., Oliveira Deborah C., Flato Uri A.P., Paoliello Ricardo C.R.ORCID, Fernandes CamiloORCID, Zandonai Cássio L., Coelho Juliana C., Barros Waldemar C., Lemos Juliana C., Bolan Renata S., Dutra Marcela M., Gebara Otavio C.E., Lopes Ana T.A., Alencar Filho Meton S., Arraes Jussara A., Hamamoto Victor A., Hernandes Mauro E.ORCID, Golin Nicole A., Santos Tiago M., Santos Renato H.N., Damiani Lucas P., Zampieri Fernando G.ORCID, Gesto João, Machado Flávia R., Rosa Régis G., Azevedo Luciano C.P., Avezum Alvaro, Lopes Renato D., Souza Thiago M.L., Berwanger Otávio, Cavalcanti Alexandre B.
Subject
Public Health, Environmental and Occupational Health,Internal Medicine,Health Policy
Reference33 articles.
1. Drug repositioning for rare diseases: knowledge-based success stories;Scherman;Therapie,2020 2. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection;Dyall;Antimicrob Agents Chemother,2014 3. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial;Arabi;Intensive Care Med,2021 4. Remdesivir for the treatment of COVID-19 - final report;Beigel;N Engl J Med,2020 5. SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and daclatasvir: a multicenter, phase III clinical trial;Merat;Clin Infect Dis,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|